期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

贝伐单抗治疗高级别脑胶质瘤研究进展 被引量：5

下载PDF
导出
摘要 脑胶质瘤是成人中枢神经系统最常见的原发性脑肿瘤，其中多数为恶性。脑胶质瘤按WHO分级分为Ⅰ-Ⅳ级，其中Ⅰ、Ⅱ级为低级别胶质瘤，Ⅲ、Ⅳ级为高级别胶质瘤（high grade glioma，HGG），也称恶性胶质瘤。高级别脑胶质瘤主要包括Ⅲ级间变性脑胶质瘤（间变性星形细胞瘤、间变性少突胶质细胞瘤等）和Ⅳ级胶质母细胞瘤（glioblastoma，GBM）。
作者 陈辉 蒋传路
机构地区 哈尔滨医科大学附属第二医院神经外科
出处 《哈尔滨医科大学学报》 CAS 北大核心 2014年第3期260-262,共3页 Journal of Harbin Medical University
关键词 恶性脑胶质瘤 血管生成 贝伐单抗 血管内皮生长因子
分类号 R739.41 [医药卫生—肿瘤]
  • 相关文献

参考文献29

  • 1We PY, Kesari S. Malignant gliomas in adults[J]. N Engl J Med, 2008,359(5 ) :492-507.
  • 2Folkman J. Tumor angiogensis: role in regulation of tumor growth [J]. Symp Soc Dev Biol, 1974,30(0) :43-52.
  • 3Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch [J]. Nat Rev Cancer, 2003,3(6) :401-410.
  • 4Parikh AA, Ellis LM. The vascular endothelial growth factor family and its receptors[J]. Hematol Oncol Clin North Am, 2004,18(5) : 951-971.
  • 5Tuettenberg J, Friedel C, Vajkoczy P. Angiogenes'is in malignant glioma-a target for antitumor therapy? [J]. Crit Rev Oncol Hema- tol, 2006,59(3) :181-193.
  • 6Ferrara N, Hillan KJ, Novotny W. Bevacizumab ( Avastin), a hu- manized anti-VEGF monoclonal antibody for cancer therapy [ J ]. Biochem Biophys Research Commun, 2005,333(2) :328-335.
  • 7Friedman HS, Prados MD, Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma[ J]. J Clin Oncol, 2009,27 (28) :4733-4740.
  • 8Narayana A, Golfinos JG, Fischer I, et al. Feasibility of using bev- acizumab with radiation therapy and temozolomide in newly diag- nosed high-grade glioma[J]. Int J Radiat Oncol Biol Phys, 2008, 72(2) :383-389.
  • 9Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year a- nalysis of the EORTC-NCIC trial[J]. Lancet Oncol, 2009,10(5): 459-466.
  • 10Lai A, Tran A, Nghiemphu PL, et al. Phase II study of bevaci- zumab plus temozolomide during and after radiation therapy for pa- tients with newly diagnosed glioblastoma muhiforme [ J ]. J Clin OneolOffiei, 2011,29 (2) : 142-148.

同被引文献74

  • 1Do|ecek TA, Propp JM, Stroup NE, et al. CBTRUS statistical report:primary brain and central nervous system tumors diagnosed in the United States in 2005-2009 [ J]. Neuro Oncol, 2012,14 ( Suppl 5 ) : v1-49. DOI : 10. 1093/neuonc/nos218.
  • 2Minniti G, Muni R, Lanzetta G, et al. Chemotherapy for glioblastoma:current treatment and future perspectives for cytotoxic and targeted agents [ J ]. Anticancer Res ,2009 ,29 (12) :5171-5184.
  • 3Wen PY, DeAngelis LM. Chemotherapy for low-grade gliomas: emerging consensus on its benefits [ J]. Neurology ,2007,68 (21) : 1762-1763. DOI : 10.1212/01. wnl. 0000266866.13748. a9.
  • 4Narayana A, Kelly P, Golfinos J, et al. Antiangiogenic therapy using bevacizumab in recurrent high-grade ghoma:impact on local control and patient survival[ J]. J Neurosurg,2009,110( 1 ) :173- 180. DOI : 10.3171/2008.4.17492.
  • 5Folkman J. Tumor angiogensis:role in regulation of tumor growth [J]. Symp Soc Dev Bio1,1974,30(0) :43-52.
  • 6Kreisl TN, Zhang W, Odia Y, et al. A Phase 1I trial of single- agent bevacizumab in patients with recurrent anaplastie glioma [J~. Neuro Oncol, 2011,13 (10) : 1143-1150. DO/: 10. 1093/ neuonc/nor091.
  • 7Nagane M,Nishikawa R,Narita Y,et al. Phase ]/ study of single- agent bevacizumab in Japanese patients with recurrent r~mlignant glioma [ J ]. Jpn J Clin Oncol, 2012,42 ( 10 ) : 887-895. DO1 : 10. 1093/jjco/hys 121.
  • 8Wong ET, Gautam S,Malchow C,et al. Bevacizumab for recurrent glioblastoma multiforme : a meta-analysis [ J ]. J Nat1 Compr Canc Netw,2011,9(4) :403-407.
  • 9Lamborn KR, Yung WK, Chang SM, et al. Progression-free survival:an important end point in evaluating therapy for recurrent high-grade gliomas [ J ]. Neuro Oneol, 2008, 10 ( 2 ) : 162-170. DOI:10. 1215/15228517-20074362.
  • 10Wick W, Puduvalli VK, Chamberlain MC, et al. Phase HI study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblasloma [ J 3. J Clin Onco1,2010,28 ( 7 ) : 1168 1174. DOI : 10.1200/JCO. 2009.23. 2595.

引证文献5

二级引证文献44

哈尔滨医科大学学报
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部